Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) FCF Payout Ratio (2019 - 2025)

Pharma-Bio Serv filings provide 7 years of FCF Payout Ratio readings, the most recent being 5.62 for Q2 2025.

  • On a quarterly basis, FCF Payout Ratio fell 128.81% to 5.62 in Q2 2025 year-over-year; TTM through Oct 2025 was 7.76, a 63.74% decrease, with the full-year FY2025 number at 7.76, down 227.48% from a year prior.
  • FCF Payout Ratio hit 5.62 in Q2 2025 for Pharma-Bio Serv, down from 2.46 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 2.38 in Q1 2024 to a low of 6.87 in Q2 2023.
  • Median FCF Payout Ratio over the past 5 years was 3.14 (2022), compared with a mean of 2.89.
  • Biggest five-year swings in FCF Payout Ratio: tumbled 163.02% in 2022 and later soared 64.23% in 2024.
  • Pharma-Bio Serv's FCF Payout Ratio stood at 0.0 in 2021, then plummeted by 177854.42% to 3.83 in 2022, then tumbled by 79.59% to 6.87 in 2023, then soared by 64.23% to 2.46 in 2024, then tumbled by 128.81% to 5.62 in 2025.
  • The last three reported values for FCF Payout Ratio were 5.62 (Q2 2025), 2.46 (Q2 2024), and 2.38 (Q1 2024) per Business Quant data.